A Study to Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The main objectives of this trial are to investigate safety, tolerability, pharmacokinetics and pharmacodynamics following single rising doses of BI 765250.
Epistemonikos ID: ce9a0b03fc0ba2710194135fcf99c76bf16a1d88
First added on: May 09, 2024